A Phase II Trial of Dasatinib in Advanced Sarcomas
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2018
At a glance
- Drugs Dasatinib (Primary)
- Indications Alveolar soft part sarcoma; Chondrosarcoma; Chordoma; Ewing's sarcoma; Gastrointestinal stromal tumours; Leiomyosarcoma; Liposarcoma; Malignant fibrous histiocytoma; Nerve sheath neoplasms; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Soft tissue sarcoma; Solitary-fibrous-tumour
- Focus Therapeutic Use
- 23 Oct 2018 Status changed from active, no longer recruiting to completed.
- 20 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 May 2017.
- 12 Oct 2016 Planned End Date changed from 1 Jun 2015 to 1 Jan 2017.